We used qRT-PCR to measure the relative mRNA expression levels of four risk genes (TIPARP, SERPINA3, MT1M, and CST2) in the normal prostate tissue cell RWPE-1 and in different tumor cell states such as LNCaP and C4-2 cell lines. The gene discussed is CST2; the disease is neoplasm.